MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that its Board of Directors has approved an amendment to the company’s Stockholder Rights Plan (the “Plan”). The amendment increases the stock ownership threshold that would cause rights issued under the Plan to become exercisable from 15% of shares outstanding to 20% of shares outstanding. No other changes were made to the Plan.
